DUBLIN, November 21, 2013 /PRNewswire/ --
Research and Markets
(http://www.researchandmarkets.com/research/r9q7dp/mammography_world) has announced the addition of the "Mammography World Markets" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
This study gives priority to those companies that are actively developing and marketing clinical laboratory instrumentation, reagents and supplies for performing diagnostic tests specifically related to breast cancer surgery and screening mammograms. This focus is primarily on the hospital market and freestanding-clinic segments and, separately, on a description of the instruments, reagents and supplies marketed by major companies in this segment. Other areas covered in this study include what is generally characterized as digital imaging techniques instruments and reagents, picture archiving communications systems (PACS) or other data storage methods, or other medical imaging technologies. The reader should consult other TriMark reports for a detailed discussion of the important individual market segments related to the mammography market, such as imaging methods, computer tomography, magnetic resonance imaging (MRI) and digital X-ray.
Mammograms are X-ray images of the breast produced from low radiation X-rays (1-3 milligrays, or mGy).
The three types of mammography systems are:
1) analog systems,
2) computed tomography (CR) systems and
3) full-field digital mammography (FFDM).
The analog systems are the conventional types, and they use X-ray films for capturing the breast images. The CR systems are also film-based, but are retrofitted with digital detectors. In FFDM, the X-ray film is replaced by solid-state detectors that convert X-rays into electrical signals. The electrical signals are used to generate images of the breast that can be viewed on a computer screen or printed on special film similar to conventional mammograms. Additionally, the radiation dose in FFDM is only 1.86 mGy radiation per view.
This report thoroughly reviews:
1) existing and emerging mammography technologies,
2) known risk factors for breast cancer,
3) breast cancer treatments and drugs,
4) types of mastectomy procedures,
5) breast reconstruction surgery, and
6) funding for breast cancer research.
Companies Mentioned:
- Abviva, Inc.
- Agendia B.V.
- AstraZeneca
- C.R. Bard, Inc.
- Biosound Esaote, Inc
- Bristol-Myers Squibb
- Canon U.S.A., Inc
- Clarient, Inc.
- Dako
- Encapsule Medical Devices, LLC.
- Fukuda Denshi Co., Ltd.
- GE Healthcare
- Genentech, Inc.
- Hitachi Medical Corporation
- Hologic, Inc.
- Konica Minolta Medical Imaging USA, Inc.
- MacKay LifeSciences
- Lantheus Medical Imaging, Inc.
- Medical Tactile, Inc
- Naviscan PET Systems, Inc.
- NeoMatrix LLC
- Philips Healthcare
- Roche Holdings, Ltd.
- Sanofi-Aventis
- Planmed
- Scanis, Inc.
- TechniScan Medical Systems
- U-Systems, Inc.
- Varian Medical Systems
- VuCOMP, Inc.
For more information visit http://www.researchandmarkets.com/research/r9q7dp/mammography_world.
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women's Health
Share this article